The inhibition of prolactin synthesis in GH3 rat pituitary tumor cells by monohydroxytamoxifen is associated with changes in the properties of the estrogen receptor-Reference-Cited by-同舟云学术

The inhibition of prolactin synthesis in GH3 rat pituitary tumor cells by monohydroxytamoxifen is associated with changes in the properties of the estrogen receptor

Published:1984-01 Issue:1 Volume:20 Page:391-395
ISSN:0022-4731
Container-title:Journal of Steroid Biochemistry
language:en
Short-container-title:Journal of Steroid Biochemistry

Author:

Tate A.C.,Lieberman M.E.,Jordan V.C.

Publisher

Elsevier BV

Subject

Endocrinology,Biochemistry

Reference22 articles.

1. Non-Steroidal Antiestrogens. Molecular Pharmacology and Antitumor Activity;Sutherland,1981

2. Estrogen and antiestrogen action in reproductive tissues and tumors;Katzenellenbogen;Recent Prog. Horm. Res.,1979

3. Metabolites of Tamoxifen in animals and man: identification, pharmacology and significance;Jordan;Breast Cancer Res. Treat.,1982

4. Estrogen control of prolactin synthesis in vitro;Lieberman,1978

5. Direct and reversible inhibition of estradiol-stimulated prolactin synthesis by antiestrogens in vitro;Lieberman;J. biol. Chem.,1983

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Turning scientific serendipity into discoveries in breast cancer research and treatment: a tale of PhD students and a 50-year roaming tamoxifen team;Breast Cancer Research and Treatment;2021-08-16

2. The SERM Saga, Something from Nothing: American Cancer Society/SSO Basic Science Lecture;Annals of Surgical Oncology;2019-03-25

3. The First Targeted Therapy to Treat Cancer: The Tamoxifen Tale;Estrogen Receptor and Breast Cancer;2018-10-17

4. The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy;Molecular and Cellular Endocrinology;2015-12

5. Tamoxifen and Prevention of Breast Cancer;Toxicology and Industrial Health;1998-09